Belite Bio Valuation
| BLTE Stock | USD 63.26 4.18 6.20% |
At this time, the firm appears to be overvalued. Belite Bio ADR shows a prevailing Real Value of $49.47 per share. The current price of the firm is $63.26. Our model approximates the value of Belite Bio ADR from analyzing the firm fundamentals such as Current Valuation of 1.87 B, shares owned by insiders of 58.60 %, and Return On Equity of -0.4 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Belite Bio's valuation include:
Price Book 17.4102 | Enterprise Value 1.9 B | Enterprise Value Ebitda (35.61) |
Overvalued
Today
Please note that Belite Bio's price fluctuation is very steady at this time. Calculation of the real value of Belite Bio ADR is based on 3 months time horizon. Increasing Belite Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Belite stock is determined by what a typical buyer is willing to pay for full or partial control of Belite Bio ADR. Since Belite Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Belite Stock. However, Belite Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 63.26 | Real 49.47 | Target 45.0 | Hype 63.46 | Naive 52.43 |
The real value of Belite Stock, also known as its intrinsic value, is the underlying worth of Belite Bio ADR Company, which is reflected in its stock price. It is based on Belite Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Belite Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Belite Bio ADR helps investors to forecast how Belite stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Belite Bio more accurately as focusing exclusively on Belite Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Belite Bio's intrinsic value based on its ongoing forecasts of Belite Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Belite Bio's closest peers. If more than one evaluation category is relevant for Belite Bio we suggest using both methods to arrive at a better estimate.
Belite Bio Cash |
|
Belite Valuation Trend
Comparing Belite Bio's enterprise value against its market capitalization is a good way to estimate the value of Belite Bio ADR uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Belite Bio Total Value Analysis
Belite Bio ADR is currently anticipated to have valuation of 1.87 B with market capitalization of 2.08 B, debt of 886 K, and cash on hands of 48.7 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Belite Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.87 B | 2.08 B | 886 K | 48.7 M |
Belite Bio Asset Utilization
One of the ways to look at asset utilization of Belite is to check how much profit was generated for every dollar of assets it reports. Belite Bio ADR shows a negative utilization of assets of -0.26 percent, losing $0.002558 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Belite Bio ADR shows how discouraging it operates for each dollar spent on its assets.Belite Bio Ownership Allocation
Belite Bio holds a total of 30.88 Million outstanding shares. Belite Bio ADR retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Belite Bio Profitability Analysis
Net Loss for the year was (31.63 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Belite Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Belite Bio and how it compares across the competition.
About Belite Bio Valuation
The stock valuation mechanism determines Belite Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Belite Bio. We calculate exposure to Belite Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Belite Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -399 K | -379.1 K |
Belite Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Belite Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 26.6 M |
Belite Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Belite Bio ADR and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Belite we look at many different elements of the entity such as Belite's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Belite Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Belite Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Belite Bio's worth.Complementary Tools for Belite Stock analysis
When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges |